Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylation

Shuichi Igarashi, Hokuto Morita, Kyla M. Bennett, Yuji Tanaka, Simone Engelender, Matthew F. Peters, Jillian K. Cooper, Jonathan D. Wood, Akira Sawa, Christopher A. Ross

Research output: Contribution to journalArticlepeer-review

59 Scopus citations

Abstract

Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by the abnormal expansion of a polyglutamine tract in the huntingtin protein. We have developed PC12 cell lines in which the expression of an N-terminal truncation of huntingtin (N63) with either wild type (23Q) or expanded polyglutamine (148Q) can be induced by the removal of doxycycline. Differentiated PC12 cells induced to express N63-148Q showed cellular toxicity reaching up to 50% at 6 days post-induction. Histone acetyltransferase (HAT) activity and global histone acetylation was significantly decreased in cells expressing truncated huntingtin with mutant but not normal huntingtin. These data suggest that altered chromatin modification via reduction in coactivator activity may cause neuronal transcriptional dysregulation and contribute to cellular toxicity.

Original languageEnglish (US)
Pages (from-to)565-568
Number of pages4
JournalNeuroreport
Volume14
Issue number4
DOIs
StatePublished - Mar 2003

Keywords

  • CBP
  • Histone acetyltransferase
  • Huntingtin
  • Huntington's disease
  • PC12
  • Polyglutamine

ASJC Scopus subject areas

  • General Neuroscience

Fingerprint

Dive into the research topics of 'Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylation'. Together they form a unique fingerprint.

Cite this